{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:21:01Z","timestamp":1790263261186,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3915-5","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T13:02:41Z","timestamp":1553518961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT\u2019AIDS cohort"],"prefix":"10.1186","volume":"19","author":[{"name":"the DAT\u2019AIDS STUDY GROUP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lions","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Cabras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Huleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gagneux-Brugnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Makinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cabi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hocqueloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cheret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hustache-Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Obry-Roguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jacomet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-5411","authenticated-orcid":false,"given":"I.","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"3915_CR1","unstructured":"Lot F, Bourdillon F. D\u00e9couvertes de s\u00e9ropositivit\u00e9 VIH et de sida en 2015. Inst Veille Sanit 2017."},{"key":"3915_CR2","first-page":"346","volume":"18","author":"DF \u00c9ditorial","year":"2017","unstructured":"\u00c9ditorial DF. Contr\u00f4ler durablement l\u2019\u00e9pid\u00e9mie VIH en France. Bull Epid\u00e9miol Hebd. 2017;18:346\u20137.","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"3915_CR3","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1097\/QAD.0000000000001597","volume":"31","author":"AJ Gourlay","year":"2017","unstructured":"Gourlay AJ, Pharris AM, Noori T, Supervie V, Rosinska M, van Sighem A, et al. Towards standardized definitions for monitoring the continuum of HIV care in Europe. AIDS Lond Engl. 2017;31:2053\u20138.","journal-title":"AIDS Lond Engl."},{"key":"3915_CR4","doi-asserted-by":"crossref","unstructured":"LeVasseur MT, Goldstein ND, Tabb LP, Olivieri-Mui BL, Welles SL. The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices. J Acquir Immune Defic Syndr 1999 2018;77:31\u201340.","DOI":"10.1097\/QAI.0000000000001555"},{"key":"3915_CR5","unstructured":"ANSM. L\u2019ANSM \u00e9tablit la RTU de Truvada dans la prophylaxie pr\u00e9-exposition au VIH - Point d\u2019information. 2015. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/L-ANSM-etablit-la-RTU-de-Truvada-dans-la-prophylaxie-pre-exposition-au-VIH-Point-d-information . Accessed 7 Mar 2018."},{"key":"3915_CR6","unstructured":"HAS. La prophylaxie pr\u00e9-exposition (PrEP) au VIH par TRUVADA. 2017. https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2017-03\/ct_eval_236_bum_truvada_cd_08032017_v4.pdf . Accessed 14 June 2018."},{"key":"3915_CR7","unstructured":"Morlat P, Agence nationale de recherches sur le sida (France), France, Conseil national du SIDA, France, Minist\u00e8re des affaires sociales et de la sant\u00e9. Prise en charge m\u00e9dicale des personnes vivant avec le VIH: rapport 2013 [pour le] Minist\u00e8re des affaires sociales et de la sant\u00e9 : recommandations du groupe d\u2019experts. Paris: la Documentation fran\u00e7aise; 2013."},{"key":"3915_CR8","unstructured":"ANSM. Truvada dans la prophylaxie Pr\u00e9-exposition (PrEP) au VIH : fin de la Recommandation Temporaire d\u2019Utilisation - Informations importantes concernant le bon usage de Truvada\u00ae dans l\u2019indication \u00ab Prophylaxie pr\u00e9-exposition (PrEP) \u00bb au VIH - Brochure destin\u00e9e aux prescripteurs. 2017."},{"key":"3915_CR9","unstructured":"Lot F, Cazein F, Ndeikoundam N, Pillonel J, Pioche C, Viriot D, et al. Infection par le VIH et IST bact\u00e9riennes. Point \u00e9pid\u00e9miologique du 26 novembre 2018. Inst Veille Sanit Sant\u00e9 Publique Fr 2018."},{"key":"3915_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1468-1293.2009.00719.x","volume":"10","author":"P Pugliese","year":"2009","unstructured":"Pugliese P, Cuzin L, Cabi\u00e9 A, Poizot-Martin I, Allavena C, Duvivier C, et al. A large French prospective cohort of HIV-infected patients: the Nadis cohort. HIV Med. 2009;10:504\u201311.","journal-title":"HIV Med."},{"key":"3915_CR11","doi-asserted-by":"crossref","unstructured":"Smith DK, Chang M-H, Duffus WA, Okoye S, Weissman S. Missed opportunities to prescribe Preexposure prophylaxis in South Carolina, 2013-2016. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018.","DOI":"10.1093\/cid\/ciy441"},{"key":"3915_CR12","doi-asserted-by":"crossref","unstructured":"Brown AE, Mohammed H, Ogaz D, Kirwan PD, Yung M, Nash SG, et al. Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)? Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2017;22.","DOI":"10.2807\/1560-7917.ES.2017.22.25.30553"},{"key":"3915_CR13","volume":"2014","author":"Y Jia","year":"2014","unstructured":"Jia Y, Aliyu MH, Jennifer Huang Z. Dynamics of the HIV epidemic in MSM. Biomed Res Int. 2014;2014:497543.","journal-title":"Biomed Res Int"},{"key":"3915_CR14","doi-asserted-by":"crossref","unstructured":"Mrav\u010d\u00edk V, Pito\u0148\u00e1k M, Hejz\u00e1k R, Jan\u00edkov\u00e1 B, Proch\u00e1zka I. HIV epidemic among men who have sex with men in the Czech Republic, 2016: high time for targeted action. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2017;22.","DOI":"10.2807\/1560-7917.ES.2017.22.48.17-00079"},{"key":"3915_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1071\/SH16070","volume":"14","author":"S Stahlman","year":"2017","unstructured":"Stahlman S, Lyons C, Sullivan PS, Mayer KH, Hosein S, Beyrer C, et al. HIV incidence among gay men and other men who have sex with men in 2020: where is the epidemic heading? Sex Health. 2017;14:5\u201317.","journal-title":"Sex Health"},{"key":"3915_CR16","doi-asserted-by":"crossref","unstructured":"Sewell J, Cambiano V, Miltz A, Speakman A, Lampe FC, Phillips A, et al. Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016. Sex Transm Infect. 2018.","DOI":"10.1136\/sextrans-2017-053439"},{"key":"3915_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1071\/SH17159","volume":"15","author":"J Frankis","year":"2018","unstructured":"Frankis J, Flowers P, McDaid L, Bourne A. Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries. Sex Health. 2018;15:144\u201350.","journal-title":"Sex Health"},{"key":"3915_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/apc.2017.0263","volume":"32","author":"A Gonz\u00e1lez-Baeza","year":"2018","unstructured":"Gonz\u00e1lez-Baeza A, Dolengevich-Segal H, P\u00e9rez-Valero I, Cabello A, T\u00e9llez MJ, Sanz J, et al. Sexualized drug use (Chemsex) is associated with high-risk sexual behaviors and sexually transmitted infections in HIV-positive men who have sex with men: data from the U-SEX GESIDA 9416 study. AIDS Patient Care STDs. 2018;32:112\u20138.","journal-title":"AIDS Patient Care STDs"},{"key":"3915_CR19","doi-asserted-by":"crossref","unstructured":"Pakianathan M, Whittaker W, Lee MJ, Avery J, Green S, Nathan B, et al. Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. 2018.","DOI":"10.1111\/hiv.12629"},{"key":"3915_CR20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/QAD.0000000000000786","volume":"29","author":"M Bracchi","year":"2015","unstructured":"Bracchi M, Stuart D, Castles R, Khoo S, Back D, Boffito M. Increasing use of \u201cparty drugs\u201d in people living with HIV on antiretrovirals: a concern for patient safety. AIDS Lond Engl. 2015;29:1585\u201392.","journal-title":"AIDS Lond Engl"},{"key":"3915_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1574889809666141127101623","volume":"9","author":"O Staltari","year":"2014","unstructured":"Staltari O, Leporini C, Caroleo B, Russo E, Siniscalchi A, De Sarro G, et al. Drug-drug interactions: antiretroviral drugs and recreational drugs. Recent Patents CNS Drug Discov. 2014;9:153\u201363.","journal-title":"Recent Patents CNS Drug Discov"},{"key":"3915_CR22","first-page":"235","volume":"75","author":"C Baecke","year":"2017","unstructured":"Baecke C, Gyssens IC, Decoutere L, van der Hilst JCH, Messiaen P. Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study. Neth J Med. 2017;75:235\u201340.","journal-title":"Neth J Med"},{"key":"3915_CR23","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/QAD.0000000000001185","volume":"30","author":"N Kojima","year":"2016","unstructured":"Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS Lond Engl. 2016;30:2251\u20132.","journal-title":"AIDS Lond Engl."},{"key":"3915_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","volume":"176","author":"AY Liu","year":"2016","unstructured":"Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176:75\u201384.","journal-title":"JAMA Intern Med"},{"key":"3915_CR25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/QAD.0000000000001718","volume":"32","author":"V-K Nguyen","year":"2018","unstructured":"Nguyen V-K, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS Lond Engl. 2018;32:523\u201330.","journal-title":"AIDS Lond Engl."},{"key":"3915_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12981-016-0089-8","volume":"13","author":"HM Scott","year":"2016","unstructured":"Scott HM, Klausner JD. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther. 2016;13:5.","journal-title":"AIDS Res Ther"},{"key":"3915_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13256-015-0679-4","volume":"9","author":"M Malahleha","year":"2015","unstructured":"Malahleha M, Ahmed K, Deese J, Nanda K, van Damme L, De Baetselier I, et al. Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report. J Med Case Rep. 2015;9:207.","journal-title":"J Med Case Rep"},{"key":"3915_CR28","doi-asserted-by":"crossref","unstructured":"Solomon MM, Schechter M, Liu AY, McMahan VM, Guanira JV, Hance RJ, et al. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B. J Acquir Immune Defic Syndr 1999 2016;71:281\u2013286.","DOI":"10.1097\/QAI.0000000000000857"},{"key":"3915_CR29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2055-6640(20)30260-0","volume":"4","author":"E Wright","year":"2018","unstructured":"Wright E, Grulich A, Roy K, Boyd M, Cornelisse V, Russell D, et al. Australasian society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018. J Virus Erad. 2018;4:143\u201359.","journal-title":"J Virus Erad"},{"key":"3915_CR30","doi-asserted-by":"crossref","unstructured":"Ross EL, Cinti SK, Hutton DW. Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men. J Acquir Immune Defic Syndr 1999 2016;72:e61\u2013e67.","DOI":"10.1097\/QAI.0000000000000987"},{"key":"3915_CR31","unstructured":"ANSM. Suivi de l\u2019utilisation de Truvada\u00ae ou g\u00e9n\u00e9riques pour une prophylaxie pr\u00e9-exposition (PrEP) au VIH \u00e0 partir du SNIIRAM. 2018. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Utilisation-de-la-prophylaxie-pre-exposition-PrEP-au-VIH-par-Truvada-ou-generiques-entre-janvier-2016-et-juillet-2017-Point-d-information . Accessed 29 June 2018."},{"key":"3915_CR32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/1471-2458-13-482","volume":"13","author":"S Baral","year":"2013","unstructured":"Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.","journal-title":"BMC Public Health"},{"key":"3915_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2334-13-200","volume":"13","author":"K Champenois","year":"2013","unstructured":"Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, et al. Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. BMC Infect Dis. 2013;13:200.","journal-title":"BMC Infect Dis"},{"key":"3915_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.puhe.2016.10.009","volume":"142","author":"M Taborelli","year":"2017","unstructured":"Taborelli M, Virdone S, Camoni L, Regine V, Zucchetto A, Frova L, et al. The persistent problem of late HIV diagnosis in people with AIDS: a population-based study in Italy, 1999-2013. Public Health. 2017;142:39\u201345.","journal-title":"Public Health"},{"key":"3915_CR35","first-page":"w14348","volume":"146","author":"KE Darling","year":"2016","unstructured":"Darling KE, Hachfeld A, Cavassini M, Kirk O, Furrer H, Wandeler G. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better. Swiss Med Wkly. 2016;146:w14348.","journal-title":"Swiss Med Wkly"},{"key":"3915_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/0956462416674093","volume":"28","author":"S O\u2019Connell","year":"2017","unstructured":"O\u2019Connell S, Enkelmann J, Sadlier C, Bergin C. Late HIV presentation - missed opportunities and factors associated with a changing pattern over time. Int J STD AIDS. 2017;28:814\u201321.","journal-title":"Int J STD AIDS"},{"key":"3915_CR37","volume-title":"Scale-up of Preexposure prophylaxis in San Francisco to impact HIV incidence","author":"R Grant","year":"2015","unstructured":"Grant R, Liu A, Hecht J, Buchbinder S, Weber S, Crouch P-C, et al. Scale-up of Preexposure prophylaxis in San Francisco to impact HIV incidence. 2015."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3915-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3915-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3915-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T09:15:08Z","timestamp":1663146908000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3915-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3915-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data are extracted from electronic medical record: NADIS\u00ae who has been approved by the French National Commission on Informatics and Liberty (CNIL 2001\/762876; MR 003: 2044467 v.0), and all patients signed an informed consent before being included in this database.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"278"}}